Revenue (Tables)

12 Months Ended

Dec. 31, 2023

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The Company categorizes revenue based on various factors such as the nature of contracts, payors, order to billing arrangements, and cash flows received by the Company, as follows:

(in thousands)	Year Ended December 31,
	2023		2022
Patient services
Capitated revenue	$	70,370	$	61,341
FFS revenue	143,134		105,444
Subtotal	213,504		166,785
Dispensary revenue	103,835		79,343
Clinical research trials and other revenue	6,900		6,355
Total	$	324,239	$	252,483